Rezolute: Late-Stage Study Targeting Hyperinsulinism

Group 1 - Rezolute is a microcap biopharma based in Redwood City, California, focusing on therapies for hypoglycemia caused by hyperinsulinism [1] - The company is currently in late-stage trials, with data from earlier stages available, making it an interesting investment opportunity [1] - Avisol Capital Partners, the team behind the analysis, consists of medical experts, finance professionals, and techies who invest their own money in the stocks they recommend [1]